Afya (AFYA) EBIT (2018 - 2026)

Afya has disclosed EBIT across 9 years of filings, most recently posting $74.8 million for Q1 2026.

• EBIT for Q1 2026 came in at $74.8 million, up 17.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $227.6 million (up 17.01% YoY), and the FY2025 annual result was $225.0 million, up 29.2% from the prior year.
• EBIT came in at $74.8 million for Q1 2026 at Afya, up from $51.6 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $74.8 million in Q1 2026 to a low of $27.9 million in Q3 2022.
• The 5-year median for EBIT is $44.2 million (2023), against an average of $44.9 million.
• Across the five-year window, EBIT jumped 98.63% in 2022 and advanced 2.66% in 2023, its largest moves.
• Afya's EBIT stood at $28.0 million in 2022, then increased by 23.26% to $34.5 million in 2023, then increased by 28.86% to $44.4 million in 2024, then advanced by 16.1% to $51.6 million in 2025, then soared by 45.07% to $74.8 million in 2026.
• The last three EBIT figures came in at $74.8 million (Q1 2026), $51.6 million (Q4 2025), and $50.9 million (Q3 2025), per Business Quant data.